Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Burning Rock Biotech (BNR) Other Operating Expenses (2019 - 2025)

Burning Rock Biotech has reported Other Operating Expenses over the past 7 years, most recently at -$6.3 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 43.81% year-over-year to -$6.3 million; the TTM value through Dec 2025 reached -$23.1 million, up 26.4%, while the annual FY2025 figure was $23.3 million, 24.79% down from the prior year.
  • Other Operating Expenses for Q4 2025 was -$6.3 million at Burning Rock Biotech, down from -$5.8 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at -$5.3 million in Q2 2025 and troughed at -$16.2 million in Q4 2021.
  • A 5-year average of -$9.6 million and a median of -$9.0 million in 2023 define the central range for Other Operating Expenses.
  • Biggest five-year swings in Other Operating Expenses: plummeted 99.08% in 2021 and later surged 43.81% in 2025.
  • Year by year, Other Operating Expenses stood at -$16.2 million in 2021, then increased by 23.76% to -$12.3 million in 2022, then soared by 43.22% to -$7.0 million in 2023, then tumbled by 59.93% to -$11.2 million in 2024, then surged by 43.81% to -$6.3 million in 2025.
  • Business Quant data shows Other Operating Expenses for BNR at -$6.3 million in Q4 2025, -$5.8 million in Q3 2025, and -$5.3 million in Q2 2025.